ArcBest (NASDAQ:ARCB – Get Free Report) had its price objective raised by equities researchers at Morgan Stanley from $135.00 to $145.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the transportation company’s stock. Morgan Stanley’s price objective would suggest a potential upside […]